Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma

被引：8
|
作者：
Kato, Takashi [1 ]
Oshikiri, Taro [1 ]
Goto, Hironobu [1 ]
Sawada, Ryuichiro [1 ]
Harada, Hitoshi [1 ]
Urakawa, Naoki [1 ]
Hasegawa, Hiroshi [1 ]
Kanaji, Shingo [1 ]
Yamashita, Kimihiro [1 ]
Matsuda, Takeru [2 ]
Kakeji, Yoshihiro [1 ]
机构：
[1] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Surg, Div Minimally Invas Surg, Kobe, Hyogo, Japan
来源：
ANTICANCER RESEARCH | 2022年 / 42卷 / 05期
关键词：
Biomarker; esophageal squamous cell carcinoma; platelet-to-lymphocyte ratio; RECURRENT LARYNGEAL NERVE; CHARACTERISTIC ROC CURVE; LAPAROSCOPIC SURGERY; CANCER; LYMPHADENECTOMY; INFLAMMATION; LEUKOCYTE; SURVIVAL; OUTCOMES;
D O I：
10.21873/anticanres.15757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background/Aim: Esophageal squamous cell carcinoma (ESCC) is a deadly malignant disease. This study examined whether the platelet-to-lymphocyte ratio (PLR) can be used as a biomarker to evaluate prognosis in patients with advanced ESCC following neoadjuvant chemotherapy (NAC) and undergoing minimally invasive esophagectomy (MIE). Patients and Methods: We examined 174 patients between January 2010 and December 2015 at the Kobe University. Of these, 121 were treated with NAC. The PLR cutoff was determined through receiver-operating characteristic curve analysis. Univariate and multivariate analyses were conducted to identify prognostic factors for overall survival (OS). Results: The PLR cutoff for OS in 121 patients was 169.6. Patients with PLR 169.6 (61.1%, p=0.001). Multivariate analysis revealed that a PLR of 169.6 was an independent factor for poor prognosis. Conclusion: PLR is an independent prognostic factor for patients with ESCC after NAC and MIE.
引用
收藏
页码：2775 / 2782
页数：8
相关论文
共 50 条
  • [1] Platelet-to-lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy
    Chen, Li-Chun
    Li, Shau-Hsuan
    Lo, Chien-Ming
    Chen, Yen-Hao
    Huang, Shun-Chen
    Wang, Yu-Ming
    Chou, Shang-Yu
    Lu, Hung-I
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : 4583 - 4590
  • [2] Effect of dynamic platelet-to-lymphocyte ratio on the prognosis of patients with esophageal squamous cell carcinoma receiving chemoradiotherapy
    He, Dan
    Du, Shulan
    He, Songyuan
    Song, Hao
    Pu, Bo
    Zhang, Guojun
    Yang, Chuan
    MEDICINE, 2023, 102 (49) : E36554
  • [3] Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma
    Yuchong Yang
    Hui Tan
    Yao Lu
    Jipeng Mei
    Mengqi Zhang
    Ming Bai
    Xia Wang
    Shaohua Ge
    Tao Ning
    Le Zhang
    Zhi Ji
    Jingjing Duan
    Yansha Sun
    Feixue Wang
    Rui Liu
    Hongli Li
    Ting Deng
    BMC Cancer, 24
  • [4] Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma
    Yang, Yuchong
    Tan, Hui
    Lu, Yao
    Mei, Jipeng
    Zhang, Mengqi
    Bai, Ming
    Wang, Xia
    Ge, Shaohua
    Ning, Tao
    Zhang, Le
    Ji, Zhi
    Duan, Jingjing
    Sun, Yansha
    Wang, Feixue
    Liu, Rui
    Li, Hongli
    Deng, Ting
    BMC CANCER, 2024, 24 (01)
  • [5] Prognostic values of preoperative platelet-to-lymphocyte ratio and platelet-related indices in advanced hypopharyngeal squamous cell carcinoma
    Lau, Hui-Ching
    Hsueh, Chi-Yao
    Chen, Qi
    Tao, Lei
    Zhou, Liang
    Deng, Weiye
    Zhang, Ming
    CLINICAL OTOLARYNGOLOGY, 2020, 45 (02) : 221 - 230
  • [6] The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes
    Albisinni, S.
    Pretot, D.
    Obeid, W. Al Hajj
    Aoun, F.
    Quackels, T.
    Peltier, A.
    Roumeguere, T.
    PROGRES EN UROLOGIE, 2019, 29 (8-9): : 423 - 431
  • [7] Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
    Shishido, Yuji
    Matsunaga, Tomoyuki
    Sawata, Shohei
    Makinoya, Masahiro
    Miyauchi, Wataru
    Miyatani, Kozo
    Uejima, Chihiro
    Morimoto, Masaki
    Murakami, Yuki
    Hanaki, Takehiko
    Kihara, Kyoichi
    Yamamoto, Manabu
    Tokuyasu, Naruo
    Takano, Shuichi
    Sakamoto, Teruhisa
    Saito, Hiroaki
    Hasegawa, Toshimichi
    Fujiwara, Yoshiyuki
    YONAGO ACTA MEDICA, 2021, 64 (03) : 249 - 259
  • [8] Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma
    Feng, Ji-Feng
    Huang, Ying
    Liu, Jin-Shi
    ONCOTARGETS AND THERAPY, 2013, 6 : 1605 - 1612
  • [9] Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma?
    Tanoglu, Alpaslan
    Karagoz, Ergenekon
    Yiyit, Nurettin
    Berber, Ufuk
    ONCOTARGETS AND THERAPY, 2014, 7 : 433 - 434
  • [10] PLATELET-TO-LYMPHOCYTE RATIO AS A MARKER OF DISEASE PROGNOSIS IN ESOPHAGEAL ADENOCARCINOMA
    Calderone, Alexander J.
    Al Lawati, Yaseen
    Ramirez-Garcialuna, Jose L.
    Alkaaki, Aroub
    Mueller, Carmen L.
    Spicer, Jonathan
    Ferri, Lorenzo E.
    Cools-Lartigue, Jonathan
    GASTROENTEROLOGY, 2021, 160 (06) : S892 - S892
12345